The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, G., Bower, K. A., Ma, C., Fang, S., Thiele, C. J., & Luo, J. (2004) · The FASEB Journal · doi:10.1096/fj.04-1551fje · Cited by 310
RetractedThe regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581
Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
Kyriakis, J. M., & Avruch, J. (2012) · Physiological Reviews · doi:10.1152/physrev.00028.2011 · Cited by 1,466
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M.-S., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,393
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911
Beaulieu, J.-M., Sotnikova, T. D., Yao, W.-D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 793
EMBI, N., RYLATT, D. B., & COHEN, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 779
Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway
Amit, S., Hatzubai, A., Birman, Y., Andersen, J. S., Ben-Shushan, E., Mann, M., Ben-Neriah, Y., & Alkalay, I. (2002) · Genes & Development · doi:10.1101/gad.230302 · Cited by 753
Neuroinflammation: The role and consequences
Lyman, M., Lloyd, D. G., Ji, X., Vizcaychipi, M. P., & Ma, D. (2014) · Neuroscience Research · doi:10.1016/j.neures.2013.10.004 · Cited by 730
The Ins and Outs of the Epithelial to Mesenchymal Transition in Health and Disease
Nieto, M. A. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154036 · Cited by 720
Mitochondrial Defects and Oxidative Stress in Alzheimer Disease and Parkinson Disease
Yan, M. H., Wang, X., & Zhu, X. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.014 · Cited by 718
Ryu, E. J., Harding, H. P., Angelastro, J. M., Vitolo, O. V., Ron, D., & Greene, L. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10690.2002 · Cited by 572
The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy
SPILLANTINI, M. G., & GOEDERT, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06900.x · Cited by 523
Wnt signaling in stem and cancer stem cells
Holland, J. D., Klaus, A., Garratt, A. N., & Birchmeier, W. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.01.004 · Cited by 504
Endoplasmic Reticulum Stress: Signaling the Unfolded Protein Response
Lai, E., Teodoro, T., & Volchuk, A. (2007) · Physiology · doi:10.1152/physiol.00050.2006 · Cited by 478
The Akt–GSK-3 signaling cascade in the actions of dopamine
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.006 · Cited by 419
Nutrient signaling to mTOR and cell growth
Jewell, J. L., & Guan, K.-L. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.01.004 · Cited by 410
From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
Banchereau, J., Pascual, V., & O'Garra, A. (2012) · Nature Immunology · doi:10.1038/ni.2406 · Cited by 401
GSK-3 is a master regulator of neural progenitor homeostasis
Kim, W.-Y., Wang, X., Wu, Y., Doble, B. W., Patel, S., Woodgett, J. R., & Snider, W. D. (2009) · Nature Neuroscience · doi:10.1038/nn.2408 · Cited by 399
Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies
Ishizawa, T., Mattila, P., Davies, P., Wang, D., & Dickson, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.389 · Cited by 394
Cook, D., Fry, M. J., Hughes, K., Sumathipala, R., Woodgett, J. R., & Dale, T. C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00830.x · Cited by 388
Alpha-synuclein biology in Lewy body diseases
Kim, W. S., Kågedal, K., & Halliday, G. M. (2014) · Alzheimer's Research & Therapy · doi:10.1186/s13195-014-0073-2 · Cited by 374
β-catenin interacts with and inhibits NF-κB in human colon and breast cancer
Deng, J., Miller, S. A., Wang, H.-Y., Xia, W., Wen, Y., Zhou, B. P., Li, Y., Lin, S.-Y., & Hung, M.-C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00154-x · Cited by 372
The role of JAK-STAT signaling within the CNS
Nicolas, C. S., Amici, M., Bortolotto, Z. A., Doherty, A., Csaba, Z., Fafouri, A., Dournaud, P., Gressens, P., Collingridge, G. L., & Peineau, S. (2013) · JAK-STAT · doi:10.4161/jkst.22925 · Cited by 351
Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders
Doyle, K. M., Kennedy, D., Gorman, A. M., Gupta, S., Healy, S. J. M., & Samali, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01374.x · Cited by 321
Spittaels, K., Van den Haute, C., Van Dorpe, J., Geerts, H., Mercken, M., Bruynseels, K., Lasrado, R., Vandezande, K., Laenen, I., Boon, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006219200 · Cited by 316
S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of Akt
Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Sahin, M., & Manning, B. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.019 · Cited by 308
Glycogen Synthase Kinase 3α-Specific Regulation of Murine Hepatic Glycogen Metabolism
MacAulay, K., Doble, B. W., Patel, S., Hansotia, T., Sinclair, E. M., Drucker, D. J., Nagy, A., & Woodgett, J. R. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.013 · Cited by 299
Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 278
α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models
Duka, T., Duka, V., Joyce, J. N., & Sidhu, A. (2009) · The FASEB Journal · doi:10.1096/fj.08-120410 · Cited by 275
Tau and α‐synuclein in susceptibility to, and dementia in, Parkinson's disease
Goris, A., Williams‐Gray, C. H., Clark, G. R., Foltynie, T., Lewis, S. J. G., Brown, J., Ban, M., Spillantini, M. G., Compston, A., Burn, D. J., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21192 · Cited by 270
Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53
Watcharasit, P., Bijur, G. N., Song, L., Zhu, J., Chen, X., & Jope, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305870200 · Cited by 262
Song, L., De Sarno, P., & Jope, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206047200 · Cited by 256
Nakka, V. P., Prakash-babu, P., & Vemuganti, R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9029-6 · Cited by 244
Rojo, A. I., Sagarra, M. R. D., & Cuadrado, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05124.x · Cited by 241
Kim, A. J., Shi, Y., Austin, R. C., & Werstuck, G. H. (2005) · Journal of Cell Science · doi:10.1242/jcs.01562 · Cited by 233
Role of glycogen synthase kinase-3 in TNF-α-induced NF-κB activation and apoptosis in hepatocytes
Schwabe, R. F., & Brenner, D. A. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00016.2002 · Cited by 231
Malagelada, C., Jin, Z. H., & Greene, L. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3928-08.2008 · Cited by 228
Samowitz, W. S., Powers, M. D., Spirio, L. N., Nollet, F., Roy, F. M. V., & Slattery, M. L. (1999) · PubMed · Cited by 225
Hattingen, E., Magerkurth, J., Pilatus, U., Mozer, A., Seifried, C., Steinmetz, H., Zanella, F., & Hilker, R. (2009) · Brain · doi:10.1093/brain/awp293 · Cited by 222
Wills, J., Jones, J., Haggerty, T., Duka, V., Joyce, J. N., & Sidhu, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.06.017 · Cited by 211
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease
Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205
Glycogen Synthase Kinase 3β Functions To Specify Gene-Specific, NF-κB-Dependent Transcription
Steinbrecher, K. A., Wilson, W., Cogswell, P. C., & Baldwin, A. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8444-8455.2005 · Cited by 205
Glycogen synthase kinase-3β is highly activated in nuclei and mitochondria
Bijur, G. N., & Jope, R. S. (2003) · NeuroReport · doi:10.1097/00001756-200312190-00025 · Cited by 203
Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLE
Su, D.-L., Lu, Z.-M., Shen, M.-N., Li, X., & Sun, L.-Y. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/347141 · Cited by 199
TGF-β-induced epithelial-mesenchymal transition: A link between cancer and inflammation
Fuxe, J., & Karlsson, M. C. I. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.05.004 · Cited by 198
Akt signal transduction dysfunction in Parkinson's disease
Timmons, S., Coakley, M. F., Moloney, A. M., & O’ Neill, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.055 · Cited by 192
Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics
Li, X., Rosborough, K. M., Friedman, A. B., Zhu, W., & Roth, K. A. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006547 · Cited by 191
Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease
Martin, E. R. (2001) · JAMA · doi:10.1001/jama.286.18.2245 · Cited by 191
Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3
Beurel, E., & Jope, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802481200 · Cited by 190
Targets for neuroprotection in Parkinson's disease
Yacoubian, T. A., & Standaert, D. G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.009 · Cited by 188
GSK‐3 in Neurodegenerative Diseases
Lei, P., Ayton, S., Bush, A. I., & Adlard, P. A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/189246 · Cited by 177
Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?
Patel, S., Doble, B. W., & Woodgett, J. R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320803 · Cited by 176
Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
Vivekanantham, S., Shah, S., Dewji, R., Dewji, A., Khatri, C., & Ologunde, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2014.982795 · Cited by 171
Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways
Murray, P. J., & Smale, S. T. (2012) · Nature Immunology · doi:10.1038/ni.2391 · Cited by 170
β-Catenin activity negatively regulates bacteria-induced inflammation
Duan, Y., Liao, A. P., Kuppireddi, S., Ye, Z., Ciancio, M. J., & Sun, J. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700545 · Cited by 168
Regulation of Akt signaling activation by ubiquitination
Yang, W.-L., Wu, C.-Y., Wu, J., & Lin, H.-K. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10508 · Cited by 166
Shin, S., Wolgamott, L., Yu, Y., Blenis, J., & Yoon, S.-O. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110195108 · Cited by 165
Garcia, B., Wei, Y., Morón, J. A., Lin, R., Javitch, J., & Galli, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009092 · Cited by 165
Gao, C., Hölscher, C., Liu, Y., & Li, L. (2012) · revneuro · doi:10.1515/rns.2011.061 · Cited by 164
Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability
Demarchi, F., Bertoli, C., Sandy, P., & Schneider, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305676200 · Cited by 162
Tau haplotypes regulate transcription and are associated with Parkinson's disease
Kwok, J. B. J., Teber, E. T., Loy, C., Hallupp, M., Nicholson, G., Mellick, G. D., Buchanan, D. D., Silburn, P. A., & Schofield, P. R. (2004) · Annals of Neurology · doi:10.1002/ana.10826 · Cited by 159
Inhibition of glycogen synthase kinase-3β protects dopaminergic neurons from MPTP toxicity
Wang, W., Yang, Y., Ying, C., Li, W., Ruan, H., Zhu, X., You, Y., Han, Y., Chen, R., Wang, Y., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.03.017 · Cited by 158
Ohteki, T., Parsons, M., Zakarian, A., Jones, R. G., Nguyen, L. T., Woodgett, J. R., & Ohashi, P. S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.99 · Cited by 158
mTOR signaling for biological control and cancer
Alayev, A., & Holz, M. K. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24351 · Cited by 157
Force, T. L., & Woodgett, J. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800077200 · Cited by 154
Regulation and Function of Glycogen Synthase Kinase-3 Isoforms in Neuronal Survival
Liang, M., & Chuang, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605178200 · Cited by 148
Moore, S., van den Bosch, M. T. J., Hunter, R. W., Sakamoto, K., Poole, A. W., & Hers, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.429936 · Cited by 144
Lim, J. H., Kim, K., Kim, S. W., Hwang, O., & Choi, H. J. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.004 · Cited by 137
Martin, L. J., Semenkow, S., Hanaford, A. R., & Wong, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.008 · Cited by 132
Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45
Hagen, T., & Vidal‐Puig, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00485-0 · Cited by 130
Arraf, Z., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.005 · Cited by 126
Yuan, Y., Yan, W.-F., Sun, J., Huang, J., Mu, Z., & Chen, N. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.11.029 · Cited by 124
Haplotypes and gene expression implicate the MAPT region for Parkinson disease
Tobin, J. E., Latourelle, J. C., Lew, M., Klein, C., Suchowersky, O., Shill, H. A., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304051.01650.23 · Cited by 123
Бычков, Э. Р., Ahmed, M. R., Dalby, K. N., & Gurevich, E. V. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04586.x · Cited by 122
Azoulay‐Alfaguter, I., Elya, R., Avrahami, L., Katz, A., & Eldar-Finkelman, H. (2014) · Oncogene · doi:10.1038/onc.2014.390 · Cited by 121
Petit-Paitel, A., Brau, F., Cazareth, J., & Chabry, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005491 · Cited by 117
Eom, T.-Y., & Jope, R. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.015 · Cited by 115
Somervaille, T. C. P., Linch, D. C., & Khwaja, A. (2001) · Blood · doi:10.1182/blood.v98.5.1374 · Cited by 115
Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Duka, T., Rusnak, M., Drolet, R. E., Duka, V., Wersinger, C., Goudreau, J. L., & Sidhu, A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6092com · Cited by 114
Wang, H., Brown, J. R., Gu, Z., Garcia, C. A., Liang, R., Alard, P., Beurel, E., Jope, R. S., Greenway, T., & Martin, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002513 · Cited by 110
Looking beyond the Wnt pathway for the deep nature of β‐catenin
Fagotto, F. (2013) · EMBO Reports · doi:10.1038/embor.2013.45 · Cited by 109
Leroy, K., Ando, K., Héraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J.-P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1276 · Cited by 103
Regulation of GSK3 isoforms by phosphatases PP1 and PP2A
Hernández, F., Langa, E., Cuadros, R., Ávila, J., & Villanueva, N. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0544-0 · Cited by 103
Urs, N. M., Snyder, J. C., Jacobsen, J. P. R., Peterson, S. M., & Caron, M. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215489109 · Cited by 103
Regulation of AMPA Receptor Trafficking and Function by Glycogen Synthase Kinase 3
Wei, J., Liu, W., & Yan, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121376 · Cited by 101
Edwards, J. P., Fujii, H., Zhou, A. X., Creemers, J. W. M., Unutmaz, D., & Shevach, E. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300199 · Cited by 98
Hernández-Baltazar, D., Mendoza‐Garrido, M. E., & Martínez‐Fong, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070951 · Cited by 97
Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens
Cortés-Vieyra, R., Bravo-Patiño, A., Valdez-Alarcón, J. J., Cajero-Juárez, M., Finlay, B. B., & Baizabal-Aguirre, V. M. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-23 · Cited by 96
Gómez‐Sintes, R., & Lucas, J. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37873 · Cited by 95
Regulation of Th1 Cells and Experimental Autoimmune Encephalomyelitis by Glycogen Synthase Kinase-3
Beurel, E., Kaidanovich‐Beilin, O., Yeh, W.-I., Song, L., Palomo, V., Michalek, S. M., Woodgett, J. R., Harrington, L. E., Eldar-Finkelman, H., Martínez, A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203057 · Cited by 94
Lee, K., Koh, S., Noh, M., Park, K. W., Lee, Y. J., & Kim, S. H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.10.055 · Cited by 92
Medical Management of Parkinson’s Disease
Encarnacion, E. V., & Hauser, R. A. (2009) · Springer eBooks · doi:10.1007/978-3-540-69960-6_90 · Cited by 89
Morales-Garcia, J. A., Susín, C., Alonso‐Gil, S., Pérez, D. I., Palomo, V., Pérez, C., Conde, S., Santos, Á., Gil, C., Martínez, A., et al. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300182g · Cited by 87
Statins in neurological disorders: An overview and update
Malfitano, A. M., Marasco, G., Proto, M., Laezza, C., Gazzerro, P., & Bifulco, M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.007 · Cited by 86
Wang, R., Xia, L., Gabrilove, J., Waxman, S., & Jing, Y. (2013) · Leukemia · doi:10.1038/leu.2012.180 · Cited by 85
Caffeine Inhibits Cell Proliferation and Regulates PKA/GSK3β Pathways in U87MG Human Glioma Cells
Ku, B. M., Lee, Y. K., Jeong, J. Y., Ryu, J., Choi, J., Kim, J. S., Cho, Y. W., Roh, G. S., Kim, H. J., Cho, G. J., et al. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0027-5 · Cited by 85
Centuori, S. M., Trad, M., LaCasse, C. J., Alizadeh, D., Larmonier, C. B., Hanke, N. T., Kartchner, J., Janikashvili, N., Bonnotte, B., Larmonier, N., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0911465 · Cited by 85
Glycogen synthase kinase-3beta is associated with Parkinson's disease
Nagao, M., & Hayashi, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.104 · Cited by 84
Meares, G. P., Mines, M. A., Beurel, E., Eom, T.-Y., Song, L., Zmijewska, A. A., & Jope, R. S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.012 · Cited by 84
Götschel, F., Kern, C., Lang, S., Sparna, T., Markmann, C., Schwager, J., McNelly, S., von Weizsäcker, F., Laufer, S., Hecht, A., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.12.015 · Cited by 84
Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Beurel, E. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00018 · Cited by 82
GSK-3β activity and hyperdopamine-dependent behaviors
Li, Y., & Gao, W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.08.001 · Cited by 80
Desplats, P., Spencer, B. J., Crews, L. A., Pathel, P., Morvinski-Friedmann, D., Kosberg, K. A., Roberts, S., Patrick, C., Winner, B., Winkler, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354522 · Cited by 80
Weise, J., Engelhorn, T., Dörfler, A., Aker, S., Bähr, M., & Hufnagel, A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.025 · Cited by 78
Kang, K., Robinson, G. W., & Hennighausen, L. G. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-4 · Cited by 77
Medical Management of Parkinson's Disease
Goldenberg, M. M. (2012) · Springer eBooks · doi:10.1007/springerreference_143638 · Cited by 71
Gąssowska-Dobrowolska, M., Czapski, G. A., Pająk, B., Cieślik, M., Lenkiewicz, A. M., & Adamczyk, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094259 · Cited by 70
Gómez‐Sintes, R., Hernández, F., Bortolozzi, A. A., Artigas, F., Ávila, J., Zaratin, P., Gotteland, J. P., & Lucas, J. J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601725 · Cited by 69
The Tau H1 Haplotype is associated with Parkinson's disease in the Norwegian population
Farrer, M. J., Skipper, L. M., Berg, M., Bisceglio, G. D., Hanson, M., Hardy, J., Adam, A., Gwinn, K. A., & Aasly, J. O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00106-4 · Cited by 69
Chiu, C., Scheuing, L., Liu, G., Liao, H., Linares, G. R., Lin, D. H., & Chuang, D. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu102 · Cited by 68
Guha, S., Cullen, J. P., Morrow, D. J., Colombo, A. E., Lally, C., Walls, D., Redmond, E. M., & Cahill, P. A. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0189-5 · Cited by 64
Mitochondrial biogenesis contributes to ischemic neuroprotection afforded by LPS pre‐conditioning
Stetler, R. A., Leak, R. K., Yin, W., Zhang, L., Wang, S., Gao, Y., & Chen, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07951.x · Cited by 64
Role of GSK‐3β activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene
Koh, S., Lee, Y., Kim, K. S., Kim, H., Kim, M., Lee, Y. J., Kim, J., Lee, K. W., & Kim, S. H. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04191.x · Cited by 63
Onyango, I. G., TUTTLE, J., & BENNETTJR, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.009 · Cited by 62
Oct4 was a novel target of Wnt signaling pathway
Li, J., Li, J. J., & Chen, B. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1148-z · Cited by 61
Javadov, S. A., Rajapurohitam, V., Kilić, A., Zeidan, A., Choi, A., & Karmazyn, M. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.023 · Cited by 60
Coant, N., Rudler, M., Gustot, T., Fasseu, M., Gandoura, S., Ragot, K., Abdel‐Razek, W., Thabut, D., Lettéron, P., Ogier‐Denis, É., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.039 · Cited by 58
GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics
Wada, A. (2009) · Frontiers in bioscience · doi:10.2741/3324 · Cited by 58
Unregulated mitochondrial GSK3β activity results in NADH:Ubiquinone oxidoreductase deficiency
King, T. D., Clodfelder‐Miller, B., Barksdale, K. A., & Bijur, G. N. (2008) · Neurotoxicity Research · doi:10.1007/bf03033861 · Cited by 57
Agrawal, S., Gollapudi, S. V. S., Gupta, S., & Agrawal, A. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.08.006 · Cited by 56
Han, G., Casson, R. J., Chidlow, G., & Wood, J. P. M. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14371 · Cited by 55
Weinreb, O., Amit, T., Bar‐Am, O., Sagi, Y., Mandel, S. A., & Youdim, M. B. H. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_69 · Cited by 52
Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Klamer, G., Song, E. Y., Ko, K.-H., O'Brien, T. A., & Dolnikov, A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710792065090 · Cited by 52
Duka, T., & Sidhu, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033329 · Cited by 51
Sudduth, T. L., Wilson, J. G., Everhart, A. L., Colton, C. A., & Wilcock, D. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031993 · Cited by 51
Overexpressed Alpha-Synuclein Regulated the Nuclear Factor-kappaB Signal Pathway
Yuan, Y., Jin, J., Yang, B., Zhang, W., Hu, J., Zhang, Y., & Chen, N. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9185-6 · Cited by 50
Choi, J.-Y., Park, H.-J., Lee, Y.-J., Byun, J., Youn, Y.-S., Choi, J. H., Woo, S., & Kang, J. L. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.199778 · Cited by 49
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
Morissette, M., Samadi, P., Tahar, A. H., Bélanger, N., & Di Paolo, T. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.011 · Cited by 47
GSK3β N-terminus binding to p53 promotes its acetylation
Eom, T.-Y., & Jope, R. S. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-14 · Cited by 46
Liu, D., Yan, P., Jiang, Z. J., Hua, T. M., Cai, W., & Xing, L. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.04.005 · Cited by 45
Altered GSK3β signaling in an infection-based mouse model of developmental neuropsychiatric disease
Willi, R., Harmeier, A., Giovanoli, S., & Meyer, U. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.012 · Cited by 42
Li, Y., Shi, J., Yang, J., Ma, Y., Cheng, L., Zeng, J., Hao, X., Ma, C., Wang, Y., & Liu, X. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.002 · Cited by 42
Cen, X., Nitta, A., Ohya, S., Zhao, Y., Ozawa, N., Mouri, A., Ibi, D., Wang, L., Suzuki, M., Saito, K., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5010-05.2006 · Cited by 42
Interventions in Wnt signaling as a novel therapeutic approach to improve myocardial infarct healing
Hermans, K. C. M., Daskalopoulos, E. P., & Blankesteijn, W. M. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-16 · Cited by 39
Ahn, J., Jang, J., Choi, J., Lee, J., Oh, S.-H., Lee, J.-H., Yoon, K., & Kim, S. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0397 · Cited by 37
SNCA,MAPT, andGSK3Bin Parkinson disease: a gene-gene interaction study
Wider, C. W., Vilariño‐Güell, C., Heckman, M. G., Jasinska-Myga, B., Ortolaza-Soto, A. I., Diehl, N. N., Crook, J. E., Cobb, S. A., Bacon, J. A., Aasly, J. O., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03297.x · Cited by 37
Hampton, P. J., Jans, R., Flockhart, R. J., Parker, G., & Reynolds, N. J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22872 · Cited by 34
Chen, P. C., Gaisina, I. N., El‐Khodor, B. F., Ramboz, S., Makhortova, N. R., Rubin, L. L., & Kozikowski, A. P. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200085z · Cited by 34
Zhang, H., Mak, S., Cui, W., Li, W., Han, R., Hu, S., Ye, M., Pi, R., & Han, Y. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.09.001 · Cited by 33
Toggling a Conformational Switch in Wnt/β-catenin Signaling: Regulation of Axin Phosphorylation
Tacchelly-Benites, O., Wang, Z.-H., Yang, E., Lee, E., & Ahmed, Y. (2013) · Bioessays · doi:10.1002/bies.201300101 · Cited by 32
GSK-3β: a signaling pathway node modulating neural stem cell and endothelial cell interactions
Li, Q., Michaud, M., Canosa, S., Kuo, A., & Madri, J. A. (2011) · Angiogenesis · doi:10.1007/s10456-011-9201-9 · Cited by 31
Crossroads of integrins and cadherins in epithelia and stroma remodeling
Epifano, C., & Pérez‐Moreno, M. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20253 · Cited by 31
GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort
Kalinderi, K., Fidani, L., Katsarou, Z., Clarimón, J., Bostantjopoulou, S., & Kotsis, A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.007 · Cited by 30
Chronic lithium neurotoxicity presenting as Parkinsonʼs disease
Lecamwasam, D., Synek, B. J. L., Moyles, K., & Ghose, K. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400920-00010 · Cited by 30
Lithium Fails to Protect Dopaminergic Neurons in the 6-OHDA Model of Parkinson’s Disease
Yong, Y., Ding, H., Fan, Z., Luo, J., & Ke, Z. (2011) · Neurochemical Research · doi:10.1007/s11064-010-0368-z · Cited by 29
Infante, J., García‐Gorostiaga, I., Sánchez‐Juan, P., Sierra, M., Martín-Gurpegui, J. L., Terrazas, J. H. I., Mateo, I., Rodríguez‐Rodríguez, E., Berciano, J., & Combarros, O. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02908.x · Cited by 27
Crosstalk Between Insulin and Toll-like Receptor Signaling Pathways in the Central Nervous system
Hemmati, F., Ghasemi, R., Ibrahim, N. M., Dargahi, L., Mohamed, Z., Raymond, A. A., & Ahmadiani, A. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8631-3 · Cited by 24
Self-citationPrasad, R., & Katiyar, S. K. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2275 · Cited by 23
Glycogen synthase kinase‐3β and tau genes interact in Parkinson's and Alzheimer's diseases
García‐Gorostiaga, I., Sánchez‐Juan, P., Mateo, I., Rodríguez‐Rodríguez, E., Sánchez‐Quintana, C., Curiel‐Olmo, S., Vázquez‐Higuera, J. L., Berciano, J., Combarros, O., & Infante, J. (2009) · Annals of Neurology · doi:10.1002/ana.21687 · Cited by 23
Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians
Das, G., Misra, A. K., Das, S. K., Ray, K., & Ray, J. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.05.031 · Cited by 22
Role of GSK-3β in isoflurane-induced neuroinflammation and cognitive dysfunction in aged rats
Li, S., Chen, X., Chen, Y.-L., Tan, L., Zhao, Y., Wang, J.-T., Xiang, Q., & Luo, A. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1154-3 · Cited by 20
Li, Y., Luo, F., Wei, L., Liu, Z., & Xu, P. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.070 · Cited by 19
Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: A study from India
Das, G., Misra, A. K., Das, S. K., Ray, K., & Ray, J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.016 · Cited by 18
Basile, G., Epifanio, A., Mandraffino, R., & Trifirò, G. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12162 · Cited by 17
Dishevelled C‐terminus: prolyl and histidinyl motifs
Wang, H., & Malbon, C. C. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2011.02291.x · Cited by 17
Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice
Gómez‐Sintes, R., Bortolozzi, A. A., Artigas, F., & Lucas, J. J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.004 · Cited by 15
Armstrong, N. J., Fagotto, F., Prothmann, C., & Rupp, R. A. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036136 · Cited by 14
GSK3β reduces risk of sporadic Parkinson's disease in ethnic Chinese
Zhao, D., Li, N., Zhang, J., Chang, X., Mao, X., Liao, Q., Tan, E., & Peng, R. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32075 · Cited by 6
Antipsychotics: Neurobiological Bases for a Therapeutic Approach
Gümrü, S., & Arıcıoğlu, F. (2013) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20130320010604 · Cited by 4
Cited by
Properties of FDA-approved small molecule protein kinase inhibitors
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.006 · Cited by 554
Xu, F., Na, L., Li, Y., & Chen, L. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00416-0 · Cited by 539
RetractedMitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment
Golpich, M., Amini, E., Mohamed, Z., Azman Ali, R., Mohamed Ibrahim, N., & Ahmadiani, A. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12655 · Cited by 532
Self-citationThere's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D. H. W., Mueller, S., Miller, T., & Miller, C. C. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.008 · Cited by 439
Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383
Metadata
- Authors
- Golpich, M., Amini, E., Hemmati, F., Ibrahim, N. M., Rahmani, B., Mohamed, Z., Raymond, A. A., Dargahi, L., Ghasemi, R., & Ahmadiani, A.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 97
- Pages
- 16-26
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W1989411375
- Cited by
- 276
- References
- 170
- FWCI
- 16.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.